Weill Cornell

The CATCH-KB database is a standardized variant repository meant to support new research into prevention of chemotherapy-induced cardiotoxicity.

After three years of work, the EXaCT-1 exome cancer test has become part of clinical cancer care at NewYork-Presbyterian, but developers have higher ambitions.

Following last year's test of FHIR Genomics, a diverse set of organizations will look to demonstrate that the standard can help them feed genomic data to EHRs.

The Qiagen-led Allele Frequency Community, founded in 2015, is improving the diagnosis of rare diseases by offering ethnically diverse reference sets.

The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.

"Precision metagenomics" and "geospatially informed medical care" are among the long-term goals of the $5 million WorldQuant Initiative for Quantitative Prediction at Weill Cornell Medicine.

Groups from Austria, Spain, Germany, and the US demonstrated that the GeneReader can reliably detect cancer mutations in tissue and liquid biopsy samples.